Reference health

Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans

https://doi.org/10.1523/jneurosci.5603-07.2008
CiteStamped reference-health badge
61/61 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 61 checked references that resolve
resolves10.1016/0165-6147(92)90064-D
Neurobiology of marijuana abuse
resolves10.1016/S0959-4388(02)00301-X
Neural systems for recognizing emotion
resolves10.1038/nature03086
A mechanism for impaired fear recognition after amygdala damage
resolves10.1007/s00213-002-1144-9
Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol
resolves10.1007/BF02245145
Reinforcing and subjective effects of oral Δ9-THC and smoked marijuana in humans
resolves10.1038/sj.npp.1300655
Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear
resolves10.1146/annurev.ne.15.030192.002033
The Role of the Amygdala in Fear and Anxiety
resolves10.1038/sj.npp.1300496
The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis
resolves10.1176/appi.ajp.2007.07030504
Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia
resolves10.1016/j.neuroimage.2005.11.003
Beyond threat: Amygdala reactivity across multiple expressions of facial affect
resolves10.1017/S0033291700054283
Reliability, validity, and clinical application of the visual analogue mood scale
resolves10.1016/0091-3057(88)90494-7
Effects of smoked marijuana on human social behavior in small groups
resolves10.1002/hbm.460020402
Statistical parametric maps in functional imaging: A general linear approach
resolves10.1016/j.pbb.2005.01.032
Endocannabinoid signaling system and brain reward: Emphasis on dopamine
resolves10.1016/j.pbb.2003.12.019
Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test
resolves10.1016/S0165-0270(02)00006-7
A method for obtaining 3-dimensional facial expressions and its standardization for use in neurocognitive studies
resolves10.1016/S0028-3908(02)00157-0
Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers
resolves10.1046/j.1460-9568.2002.02192.x
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
resolves10.1111/j.1460-9568.2004.03293.x
Context‐dependent effects of CB1 cannabinoid gene disruption on anxiety‐like and social behaviour in mice
resolves10.1006/nimg.2002.1179
The Amygdala Response to Emotional Stimuli: A Comparison of Faces and Scenes
resolves10.1016/S0893-133X(02)00373-1
Dextroamphetamine Modulates the Response of the Human Amygdala
resolves10.1001/archpsyc.62.2.146
A Susceptibility Gene for Affective Disorders and the Response of the Human Amygdala
resolves10.1016/j.biopsych.2005.10.015
Antidepressant Drug Treatment Modifies the Neural Processing of Nonconscious Threat Cues
resolves10.1016/S1053-8119(18)31587-8
Generalisability, Random Effects & Population Inference
resolves10.1007/BF00433061
Drug preference and mood in humans: Diazepam
resolves10.1523/JNEUROSCI.21-06-02067.2001
The Primate Amygdala Mediates Acute Fear But Not the Behavioral and Physiological Components of Anxious Temperament
resolves10.1523/JNEUROSCI.0153-06.2006
Cannabinoid CB1 Receptor Mediates Fear Extinction via Habituation-Like Processes
resolves10.1523/JNEUROSCI.21-23-09506.2001
Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission
resolves10.1016/S0091-3057(98)00264-0
Responses to Oral Δ9-Tetrahydrocannabinol in Frequent and Infrequent Marijuana Users
resolves10.1523/JNEUROSCI.3984-05.2005
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
resolves10.1523/JNEUROSCI.0707-06.2006
Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs
resolves10.1146/annurev.neuro.23.1.155
Emotion Circuits in the Brain
resolves10.1038/nature00839
The endogenous cannabinoid system controls extinction of aversive memories
resolves10.1007/s00213-001-0946-5
Involvement of CB1 cannabinoid receptors in emotional behaviour
resolves10.1038/nn1494
Neural correlates of genetically abnormal social cognition in Williams syndrome
resolves10.1038/383812a0
A differential neural response in the human amygdala to fearful and happy facial expressions
resolves10.1016/0166-4328(93)90059-Y
An acute dose of δ9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity
resolves10.1016/0306-4522(93)90050-P
The intercalated cell masses project to the central and medial nuclei of the amygdala in cats
resolves10.1111/j.1460-9568.2005.03916.x
Inhibition of restraint stress‐induced neural and behavioural activation by endogenous cannabinoid signalling
resolves10.1001/archpsyc.62.3.282
Dose-Dependent Decrease of Activation in Bilateral Amygdala and Insula by Lorazepam During Emotion Processing
resolves10.1006/nimg.2002.1087
Functional Neuroanatomy of Emotion: A Meta-Analysis of Emotion Activation Studies in PET and fMRI
resolves10.1016/j.biopsych.2005.08.012
Association between Amygdala Hyperactivity to Harsh Faces and Severity of Social Anxiety in Generalized Social Phobia
resolves10.1016/j.conb.2004.03.015
Human emotion and memory: interactions of the amygdala and hippocampal complex
resolves10.1016/j.neuropharm.2003.08.003
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions
resolves10.1016/S0163-7258(01)00130-9
The endocannabinoid nervous system
resolves10.1016/S0006-3223(00)00828-3
Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study
resolves10.1038/nn1944
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
resolves10.1126/science.276.5321.2050
Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
resolves10.1016/0006-3223(86)90003-X
Antianxiety effect of cannabis: Involvement of central benzodiazepine receptors
resolves10.1073/pnas.0509184103
Glucocorticoids reduce phobic fear in humans
resolves10.1001/archpsyc.59.11.1027
Increased Amygdala Activation to Angry and Contemptuous Faces in Generalized Social Phobia
resolves10.1002/1522-2594(200010)44:4<525::AID-MRM5>3.0.CO;2-L
Three-dimensional tailored RF pulses for the reduction of susceptibility artifacts inT*2-weighted functional MRI
resolves10.1523/JNEUROSCI.22-20-09099.2002
Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease
resolves10.1006/nimg.2001.0978
Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain
resolves10.1016/j.nlm.2006.05.008
Endogenous cortisol level interacts with noradrenergic activation in the human amygdala
resolves10.1016/j.pbb.2005.01.029
Endocannabinoid system and stress and anxiety responses
resolves10.1007/s00213-002-1033-2
Comparison of the subjective effects of Δ 9 -tetrahydrocannabinol and marijuana in humans
resolves10.1523/JNEUROSCI.18-01-00411.1998
Masked Presentations of Emotional Facial Expressions Modulate Amygdala Activity without Explicit Knowledge
resolves10.1097/00008877-200509000-00005
A role for cannabinoid CB1 receptors in mood and anxiety disorders
resolves10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O
A unified statistical approach for determining significant signals in images of cerebral activation
resolves10.1016/S0165-0173(02)00248-5
The human amygdala and the emotional evaluation of sensory stimuli
The 2 references without a DOI — listed, not checked
no DOI — not checkedPharmacological characterization of cannabinoids in the elevated plus maze
no DOI — not checkedWalter B Blecker C Kirsch P Sammer G Schlienle A Stark R Vaitl D (2003) Paper presented at Ninth International Conference on Functional Mapping of the Human Brain (June, New York, NY), MARINA: an easy to use tool for the creation of MAsks for Region of INterest Analyses.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1523/jneurosci.5603-07.2008"><img src="https://citestamp.com/citestamped/10.1523/jneurosci.5603-07.2008/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1523/jneurosci.5603-07.2008/badge.svg)](https://citestamp.com/citestamped/10.1523/jneurosci.5603-07.2008)